A detailed history of Exane Derivatives transactions in Brandywine Realty Trust stock. As of the latest transaction made, Exane Derivatives holds 55 shares of BDN stock, worth $309. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55
Previous 55 -0.0%
Holding current value
$309
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 27, 2021

SELL
$8.61 - $12.27 $99,876 - $142,332
-11,600 Reduced 99.53%
55 $0
Q3 2020

Oct 06, 2020

BUY
$9.65 - $11.75 $110,482 - $134,525
11,449 Added 5557.77%
11,655 $120,000
Q3 2019

Oct 15, 2019

SELL
$14.09 - $15.18 $6,580 - $7,089
-467 Reduced 69.39%
206 $3,000
Q2 2019

Jul 12, 2019

BUY
$14.19 - $16.13 $9,549 - $10,855
673 New
673 $0
Q4 2017

Jan 29, 2018

SELL
$17.1 - $18.58 $34 - $37
-2 Closed
0 $0
Q3 2017

Oct 18, 2017

BUY
$16.58 - $17.55 $33 - $35
2
2 $0

Others Institutions Holding BDN

About BRANDYWINE REALTY TRUST


  • Ticker BDN
  • Exchange NYSE
  • Sector Real Estate
  • Industry REIT—Office
  • Shares Outstandng 171,570,000
  • Market Cap $964M
  • Description
  • Brandywine Realty Trust (NYSE: BDN) is one of the largest, publicly traded, full-service, integrated real estate companies in the United States with a core focus in the Philadelphia, Austin and Washington, D.C. markets. Organized as a real estate investment trust (REIT), we own, develop, lease and manage an urban, town center and transit-oriente...
More about BDN
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.